rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Xylem Inc. Common Stock New

XYL · NYSE

IndustrialsMachineryNot moving yet

XYL stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 36 weeks. It is 9.0% below that average now. Machinery: 24% of its 144 stocks in an uptrend (−3 points in four weeks); Industrials: 27% (−4 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 36
Industry in uptrend
24% -4 in 4 wk
Insider buys, 12 months
$282K
Insider sales, 12 months
$2.8M
Officials’ trades on record
19

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.

17 Apr – 16 Oct
25%41%56%Apr 26Jun 26Jul 26Sep 26Oct 26

Machinery: A minority of its stocks are in an uptrend and the share has been slipping. Industrials: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$2.0M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

19 disclosed lines: House 19, Senate 0, executive 0; 5 people.

WhoDidAmountTraded
Susie Lee House: U.S. House ClerkNV03soldjoint$1k–$15k30 Nov 2022filed 29 Dec 2022
Katherine M. Clark House: U.S. House ClerkMA05soldspouse$1k–$15k4 Jun 2021filed 15 Aug 2021
Katherine M. Clark House: U.S. House ClerkMA05soldspouse$1k–$15k4 Jun 2021filed 15 Aug 2021
Katherine M. Clark House: U.S. House ClerkMA05boughtspouse$1k–$15k5 Nov 2020filed 28 Dec 2020
Katherine M. Clark House: U.S. House ClerkMA05boughtspouse$1k–$15k5 Nov 2020filed 28 Dec 2020
Susie Lee House: U.S. House ClerkNV03sold$1k–$15k19 Oct 2020filed 8 Dec 2020
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k12 Jul 2019filed 29 Aug 2019
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k25 Jun 2019filed 18 Jul 2019
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k25 Apr 2019filed 9 May 2019
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k12 Apr 2019filed 9 May 2019
Jackie Speier House: U.S. House ClerkCA14sold$1k–$15k30 Jul 2018filed 2 Aug 2018
James B. Renacci House: U.S. House ClerkOH16bought$15k–$50k27 Jul 2018filed 9 Aug 2018

Insiders

Buy orders, 12 months1
Sale orders, 12 months3
Buyers · sellers1 · 3
WhoDidSharesTraded
Geri-Michelle McShaneSVP, CAOsold4,269at $117.467 May 2026filed 8 May 2026
Jerome A. PeribereDirectorbought1,210at $116.614 May 2026filed 4 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Geri-Michelle McShane Company insiderSVP, CAO · last 1 Oct 20260 · 7
Andrea Michele van der Berg Company insiderEVP & Chief Financial Officer · last 1 Sep 20260 · 0
Joseph Patrick Johnston Company insiderEVP & President, AW · last 1 Sep 20260 · 0
D. Christian Koch Company insiderDirector · last 13 Aug 20260 · 0
Earl Ray Ellis Company insiderDirector · last 14 May 20260 · 0
Jerome A. Peribere Company insiderDirector · last 14 May 20261 · 0
Lila Tretikov Company insiderDirector · last 14 May 20261 · 1
Lisa Glatch Company insiderDirector · last 14 May 20260 · 1
Mark D. Morelli Company insiderDirector · last 14 May 20260 · 0
Robert F. Friel Company insiderDirector · last 14 May 20260 · 0
Uday Yadav Company insiderDirector · last 14 May 20260 · 0
Victoria D. Harker Company insiderDirector · last 14 May 20260 · 6

Same industry

HLP Hongli GroupLeading+154%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202538.5%
Operating profit marginFY 2025 · to 31 Dec 202513.5%
Free cash flow marginFY 2025 · to 31 Dec 202510.1%
Return on capital employedFY 2025 · to 31 Dec 20258.3%
Cash conversionFY 2025 · to 31 Dec 2025130%
Debt to equityFY 2025 · to 31 Dec 20250.22×
Research spendFY 2025 · to 31 Dec 20252.5%
Share count trendFY 2025 · to 20 Feb 2026-0.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$1.5B
Free cash flowFY 2025 · to 31 Dec 2025$910.0M

Analyst forecasts

No analyst forecasts yet.